Atlas Trials

Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

Clinical trial NCT02298595 · WITHDRAWN

Trial details

NCT number
NCT02298595
Sponsor
Julie E. Bauman, MD, MPH
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Carcinoma, SquamousSquamous Cell CarcinomaOropharyngeal NeoplasmsOropharyngeal Cancer
Start date
2016-08-01
Primary completion
2019-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.